Table 1.
Outcome | Non-PCOS |
PCOS |
p-value | OR | 95% CI |
---|---|---|---|---|---|
N = 35,340 | N = 3626 | ||||
Cesarean delivery | 9537 (27.4) | 1373 (39.2) | <0.001 | 1.54 | 1.43–1.66 |
Preterm birtha | 2686 (7.6) | 559 (15.5) | <0.001 | 1.74 | 1.53–1.98 |
Apgar score at 5 min < 7 | 648 (1.8) | 151 (4.2) | <0.001 | 1.46 | 1.10–1.93 |
BWT < 2500 gb | 2206 (6.2) | 414 (11.4) | <0.001 | 0.86 | 0.70–1.07 |
SGA | 2468 (7.2) | 306 (8.7) | 0.001 | 0.98 | 0.84–1.14 |
BWT > 4000 g | 4473 (13.0) | 477 (13.6) | 0.287 | 1.07 | 0.95–1.20 |
SCN admissionb | 2783 (7.9) | 502 (14.1) | <0.001 | 1.21 | 1.05–1.40 |
Stillbirth | 216 (0.6) | 64 (1.8) | <0.001 | 1.23 | 0.80–1.89 |
Perinatal mortality | 260 (0.7) | 84 (2.3) | <0.001 | 1.49 | 1.02–2.18 |
ICD diagnoses originating in perinatal period | N = 34,756 | N = 3552 | p-value | OR | 95% CI |
Any conditions | 5371 (15.5) | 912 (25.7) | <0.001 | 1.39 | 1.25–1.53 |
Short GA and/or low BWTc | 1974 (5.7) | 417 (11.7) | <0.001 | 1.03 | 0.83–1.27 |
Infections in perinatal period | 1087 (3.1) | 214 (6.0) | <0.001 | 1.36 | 1.14–1.63 |
Respiratory distress | 1511 (4.3) | 337 (9.5) | <0.001 | 1.35 | 1.14–1.59 |
Other pulmonary problems | 997 (2.9) | 234 (6.6) | <0.001 | 1.34 | 1.12–1.61 |
Feeding problems | 1261 (3.6) | 256 (7.2) | <0.001 | 1.28 | 1.09–1.52 |
Transitory carbohydrate metabolism disorders | 651 (1.9) | 144 (4.1) | <0.001 | 1.24 | 0.99–1.56 |
Hemorrhagic, hematological disorders | 2073 (6.0) | 382 (10.8) | <0.001 | 1.26 | 1.08–1.46 |
Cardiac conditions | 243 (0.7) | 45 (1.3) | <0.001 | 0.77 | 0.52–1.13 |
Source: Reproduced with permission from The American College of Obstetricians and Gynecologists from Doherty et al.6 Published by Wolters Kluwer Health, Inc.
OR: odds ratio; CI: confidence interval; BWT: birth weight; SGA: small-for-gestational age; GA: gestational age; SCN: special care nursery.
Data shown as n (%) and using the adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) summarizing the effects of maternal PCOS on neonatal outcomes while controlling for other risk factors. p-values shown were generated using univariate chi-square test for the univariate comparisons between the groups. All statistically significant effects of PCOS in the adjusted comparisons are shown in boldface.
Recording of a PCOS diagnosis was identified among all women who were hospitalized with a PCOS diagnosis (International Classification of Diseases, 10th Revision (ICD-10): E28.2 or International Classification of Diseases, 9th Revision (ICD-9): 256.4) using the Hospital Morbidity System hospitalization records between 1980 and 2011. Study participants with a recorded PCOS diagnosis were defined as women who had reached 15 years of age in 1980, or later, and who were hospitalized with PCOS as one of the diagnoses noted on their admission between January 1997 and April 2011.
All outcomes adjusted for IVF, Ethnicity (Caucasian, Indigenous, Asian and Other), multiple pregnancy, maternal age (<20, 20–29, 30–39, 40+), parity (0, 1–4, 5+), time epoch (years <1990, 1990–1999, 2000–2011), smoking during pregnancy (yes, no or unreported), maternal hypertension, pre-existing and gestational diabetes and preeclampsia.
Adjustments for additional risk factors—cesarean delivery: maternal mental health disorders, antepartum hemorrhage; preterm birth: maternal mental health disorders, antepartum hemorrhage; Apgar score at 5 min < 7: maternal mental health disorders, gestational age at delivery, fetus small-for-gestational age, fetus large-for-gestational age; BWT < 2500 g and SGA and BWT > 4000 g: antepartum hemorrhage, gestational age at delivery; SCN admission: maternal mental health disorders, antepartum hemorrhage, gestational age at delivery; stillbirth and perinatal mortality: gestational age at delivery.
On 34,650 and 3488 pregnancies non-PCOS and PCOS neonates, respectively, when gestational age at delivery was recorded.
Excluding stillbirths.
High birth weight (ICD diagnoses P08) recorded in 101 (0.3%) and 29 (0.8%) offspring of women with and without PCOS diagnosis, respectively.